Therapeutic effects of cefluprenam (CLFP) on polymicrobial infections associated with Enterococcus faecalis in rat pyometra model

International Journal of Antimicrobial Agents

Volumn 8, Issue 1, 1997, Pages 7-11

  Mikamo, Hiroshige ^a   Kawazoe, Kyoko ^a   Izumi, Koji ^a   Hachiya, Shigeru ^b   Satoh, Masaru ^b   Munakata, Keiichi ^b   Tamaya, Teruhiko ^a  

^a GIFU UNIVERSITY   (Japan)

^b EISAI CO LTD   (Japan)

Author keywords

cefluprenam; Enterococcus faecalis; rat pyometra

Indexed keywords

CEFLUPRENAM; CEFPIROME; CEFTAZIDIME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTEROIDES FRAGILIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TISSUE LEVEL; ENTEROCOCCUS; FEMALE; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METRITIS; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; RAT;

EID: 0030930954     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(96)00329-9     Document Type: Article

References (19)

1. Evans AC, Chinn AL. The enterococci: with special reference to their association with human disease. J Bacteriol 1947;54:495-512.
2. Lewis CM, Zervos MJ. Clinical manifestations of enterococcal infection. Eur J Clin Microbiol Infect Dis 1990;9:111-117.
3. Rantz LA, Kirby WMM. Enterococcic infections: an evaluation of the importance of fecal streptococci and related organisms in the causation of human disease. Arch Int Med 1943;7:516-528.
4. Hite KE, Locke M. Hesseltine HC. Synergism in experimental infection with nonsporulating anaerobic bacteria. J Infect Dis 1949;84:1-9.
5. Hagland LA, Flournoy DJ, Gilmore MS, Huycke MM. Enterococcus: an old pathogen with new tricks. J Oklhoma State Med Assoc 1991;84:305-309.
6. Stark, JM. Antibiotic activity of haemolytic enterococci. Lancet 1960;i:733-734.
7. Tight RR. Ampicillin therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother 1980;18:307-310.
8. Wells CL, Jechorek R P, Maddaus MA, Simmons RL. Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Antimicrob Agents Chemother 1988;32:1769-1775.
9. Weinstein AJ, Lentnek AL. Cephalosporin-aminoglycoside synergism in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1976;9:983-987.
10. Toyosawa T, Miyazaki S, Tsuji A, Yamaguchi K, Goto S. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin. Antimicrob Agents Chemother 1993;37:60-66.
11. Watanabe N, Hiruma R, Katsu K. In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum. Antimicrob Agents Chemother 1992;36:589-597.
12. Hata K, Otsuki M, Nishino T. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin with a broad antibacterial spectrum. Antimicrob Agents Chemother 1992;36:1894-1901.
13. Patterson JE, Masecar BL, Kauffman CA, Schaberg DR, Hierholzer WJ Jr, Zervos M. Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous. J Infect Dis 1988;158:212-216.
14. Kaye D. Enterococci. Arch Int Med 1982;142:2006-2009.
15. Barrall DT, Kenney PR, Slotman GJ, Burchard KW. Enterococcal bacteremia in surgical patients. Arch Surg 1985;120:57-63.
16. Gullberg RM, Homann SR, Phari JP. Enterococcal bacteremia: analysis of 75 episodes. Rev Infect Dis 1989;11:74-85.
17. Klimek JJ, Ajemian ER, Gracewski J, Klemas B, Quintiliani R. A prospective analysis of hospital-aquired fever in obstetric and gynecologic patients. JAMA 1982;247:3340-3343.
18. Whiteside M, Moore J, Ratzam K. An investigation of enterococcal bacteremia. Am J Infect Control 1983;11:125-129.
19. Nichols RL, Muzik AC. Enterococcal infections in surgical patients: the mystery continues. Clin Infect Dis 1992;15:72-76.